1. Message Pharmaceuticals, Inc. (4 from 9 patents)

2. Other (2 from 832,680 patents)

3. National Institutes of Health (nih) (2 from 30 patents)

4. Raptor Pharmaceutical Corp (2 from 6 patents)

5. National Institutes of Health, a Component of the US Dept. of Health & Human Services (1 from 3,435 patents)

6. The National Institutes of Health and Axonyx, Inc. (1 from 1 patent)

7. Torreypines Therapeutics, Inc. (1 patent)

1. 8691864 - Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof

2. 8258172 - Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof

3. 7786162 - Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof

4. 7498307 - Combinations of DnaK inhibitors with known antibacterial agents

5. 7153882 - Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof

6. 7037660 - Methods for detecting and quantifying binding and inhibition of binding of species to nucleic acids

7. 7001924 - Inhibitors of RNase P proteins as antibacterial compounds

8. 6872850 - Small molecule inhibitors of secretion of proteins encoded by ARE-mRNAs

9. 6630589 - Identification of compounds for the treatment or prevention of proliferative diseases